HK Stock MarketDetailed Quotes

01093 CSPC PHARMA

Watchlist
  • 6.180
  • +0.060+0.98%
Market Closed Jul 12 16:08 CST
73.29BMarket Cap10.98P/E (TTM)

CSPC PHARMA Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Turnover
11.54%8.98B
1.66%31.45B
1.57%23.87B
3.01%16.08B
2.28%8.05B
11.02%30.94B
13.83%23.5B
12.93%15.61B
16.94%7.87B
11.73%27.87B
Operating income
11.54%8.98B
1.66%31.45B
1.57%23.87B
3.01%16.08B
2.28%8.05B
11.02%30.94B
13.83%23.5B
12.93%15.61B
16.94%7.87B
11.73%27.87B
Cost of sales
1.87%-2.49B
-6.83%-9.27B
-10.29%-7.07B
-13.37%-4.84B
-22.87%-2.53B
-28.95%-8.68B
-28.62%-6.41B
-29.53%-4.27B
-33.14%-2.06B
-7.59%-6.73B
Operating expenses
1.87%-2.49B
-6.83%-9.27B
-10.29%-7.07B
-13.37%-4.84B
-22.87%-2.53B
-28.95%-8.68B
-28.62%-6.41B
-29.53%-4.27B
-33.14%-2.06B
-7.59%-6.73B
Gross profit
17.70%6.5B
-0.36%22.18B
-1.70%16.79B
-0.89%11.24B
-5.03%5.52B
5.31%22.26B
9.11%17.08B
7.73%11.34B
12.09%5.81B
13.11%21.14B
Selling expenses
-18.97%-2.96B
11.58%-9.14B
13.34%-7.03B
9.39%-4.9B
11.91%-2.49B
1.01%-10.34B
-4.32%-8.11B
-1.69%-5.41B
-7.77%-2.82B
-11.37%-10.44B
Administrative expenses
-26.51%-332.83M
-1.43%-1.19B
2.08%-855.97M
5.17%-535.64M
-1.07%-263.08M
-16.14%-1.17B
-16.82%-874.16M
-13.64%-564.82M
-20.08%-260.3M
-6.78%-1.01B
Research and development expenses
-16.04%-1.17B
-21.17%-4.83B
-25.95%-3.68B
-22.27%-2.3B
-11.77%-1.01B
-16.14%-3.99B
-16.43%-2.92B
-16.81%-1.88B
-30.41%-901.52M
-18.78%-3.43B
Special items of operating profit
41.09%59.06M
-48.38%420.59M
-8.36%405.88M
-13.72%214.78M
164.60%41.86M
49.32%814.85M
-22.03%442.91M
-54.52%248.93M
-148.06%-64.8M
-6.64%545.69M
Operating profit
16.13%2.09B
-1.82%7.44B
0.27%5.63B
-0.47%3.71B
2.37%1.8B
11.47%7.57B
8.24%5.62B
2.38%3.73B
-1.68%1.76B
12.19%6.79B
Financing cost
-37.84%-6.11M
-4.04%-25.9M
-12.51%-16.88M
-10.29%-10.72M
-54.97%-4.43M
-224.78%-24.89M
-132.70%-15M
-103.22%-9.72M
-0.88%-2.86M
37.34%-7.66M
Share of profits of associates
-24.61%-15.01M
3.40%-41.07M
29.06%-32.97M
39.72%-16.25M
-42.31%-12.05M
-77.91%-42.51M
-119.94%-46.48M
-38.43%-26.95M
38.39%-8.46M
-14.23%-23.89M
Share of profit from joint venture company
-187.38%-13.48M
-148.43%-13.13M
-113.24%-5.5M
-108.12%-2.26M
-131.76%-4.69M
-41.49%27.11M
15.51%41.56M
32.14%27.78M
46.54%14.77M
34.51%46.34M
Special items of earning before tax
----
-31.63%32.86M
--32.86M
----
----
28.64%48.07M
----
----
----
-88.78%37.37M
Earning before tax
15.57%2.06B
-2.54%7.39B
0.23%5.61B
-1.02%3.68B
0.97%1.78B
10.74%7.58B
7.18%5.6B
1.54%3.72B
-1.13%1.76B
7.14%6.85B
Tax
-37.35%-428.35M
2.48%-1.32B
5.98%-964.74M
9.95%-623.51M
5.39%-311.86M
-16.50%-1.35B
-24.40%-1.03B
-25.03%-692.38M
-15.08%-329.63M
0.26%-1.16B
After-tax profit from continuing operations
10.94%1.63B
-2.56%6.07B
1.62%4.65B
1.02%3.06B
2.43%1.47B
9.56%6.23B
3.95%4.57B
-2.64%3.03B
-4.23%1.43B
8.78%5.69B
Earning after tax
10.94%1.63B
-2.56%6.07B
1.62%4.65B
1.02%3.06B
2.43%1.47B
9.56%6.23B
3.95%4.57B
-2.64%3.03B
-4.23%1.43B
8.78%5.69B
Minority profit
-57.68%17.04M
41.74%199.37M
45.84%150.38M
49.57%91.05M
35.22%40.26M
69.59%140.66M
66.96%103.11M
30.80%60.88M
14.11%29.77M
19.59%82.94M
Profit attributable to shareholders
12.88%1.61B
-3.58%5.87B
0.60%4.49B
0.03%2.97B
1.73%1.43B
8.67%6.09B
3.06%4.47B
-3.15%2.97B
-4.55%1.4B
8.63%5.61B
Basic earnings per share
13.51%0.1361
-3.21%0.4947
0.93%0.3784
0.24%0.2495
1.70%0.1199
9.00%0.5111
3.39%0.3749
-2.85%0.2489
-4.07%0.1179
8.64%0.4689
Diluted earnings per share
13.51%0.1361
-3.21%0.4947
0.91%0.3783
0.24%0.2495
1.70%0.1199
9.00%0.5111
3.39%0.3749
-2.85%0.2489
-4.07%0.1179
8.64%0.4689
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
--
Unqualified Opinion
--
--
--
Unqualified Opinion
--
--
--
Unqualified Opinion
Auditor
--
Deloitte - Guan Huang Chen Fang Certified Public Accountants
--
--
--
Deloitte - Guan Huang Chen Fang Certified Public Accountants
--
--
--
Deloitte - Guan Huang Chen Fang Certified Public Accountants
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Turnover 11.54%8.98B1.66%31.45B1.57%23.87B3.01%16.08B2.28%8.05B11.02%30.94B13.83%23.5B12.93%15.61B16.94%7.87B11.73%27.87B
Operating income 11.54%8.98B1.66%31.45B1.57%23.87B3.01%16.08B2.28%8.05B11.02%30.94B13.83%23.5B12.93%15.61B16.94%7.87B11.73%27.87B
Cost of sales 1.87%-2.49B-6.83%-9.27B-10.29%-7.07B-13.37%-4.84B-22.87%-2.53B-28.95%-8.68B-28.62%-6.41B-29.53%-4.27B-33.14%-2.06B-7.59%-6.73B
Operating expenses 1.87%-2.49B-6.83%-9.27B-10.29%-7.07B-13.37%-4.84B-22.87%-2.53B-28.95%-8.68B-28.62%-6.41B-29.53%-4.27B-33.14%-2.06B-7.59%-6.73B
Gross profit 17.70%6.5B-0.36%22.18B-1.70%16.79B-0.89%11.24B-5.03%5.52B5.31%22.26B9.11%17.08B7.73%11.34B12.09%5.81B13.11%21.14B
Selling expenses -18.97%-2.96B11.58%-9.14B13.34%-7.03B9.39%-4.9B11.91%-2.49B1.01%-10.34B-4.32%-8.11B-1.69%-5.41B-7.77%-2.82B-11.37%-10.44B
Administrative expenses -26.51%-332.83M-1.43%-1.19B2.08%-855.97M5.17%-535.64M-1.07%-263.08M-16.14%-1.17B-16.82%-874.16M-13.64%-564.82M-20.08%-260.3M-6.78%-1.01B
Research and development expenses -16.04%-1.17B-21.17%-4.83B-25.95%-3.68B-22.27%-2.3B-11.77%-1.01B-16.14%-3.99B-16.43%-2.92B-16.81%-1.88B-30.41%-901.52M-18.78%-3.43B
Special items of operating profit 41.09%59.06M-48.38%420.59M-8.36%405.88M-13.72%214.78M164.60%41.86M49.32%814.85M-22.03%442.91M-54.52%248.93M-148.06%-64.8M-6.64%545.69M
Operating profit 16.13%2.09B-1.82%7.44B0.27%5.63B-0.47%3.71B2.37%1.8B11.47%7.57B8.24%5.62B2.38%3.73B-1.68%1.76B12.19%6.79B
Financing cost -37.84%-6.11M-4.04%-25.9M-12.51%-16.88M-10.29%-10.72M-54.97%-4.43M-224.78%-24.89M-132.70%-15M-103.22%-9.72M-0.88%-2.86M37.34%-7.66M
Share of profits of associates -24.61%-15.01M3.40%-41.07M29.06%-32.97M39.72%-16.25M-42.31%-12.05M-77.91%-42.51M-119.94%-46.48M-38.43%-26.95M38.39%-8.46M-14.23%-23.89M
Share of profit from joint venture company -187.38%-13.48M-148.43%-13.13M-113.24%-5.5M-108.12%-2.26M-131.76%-4.69M-41.49%27.11M15.51%41.56M32.14%27.78M46.54%14.77M34.51%46.34M
Special items of earning before tax -----31.63%32.86M--32.86M--------28.64%48.07M-------------88.78%37.37M
Earning before tax 15.57%2.06B-2.54%7.39B0.23%5.61B-1.02%3.68B0.97%1.78B10.74%7.58B7.18%5.6B1.54%3.72B-1.13%1.76B7.14%6.85B
Tax -37.35%-428.35M2.48%-1.32B5.98%-964.74M9.95%-623.51M5.39%-311.86M-16.50%-1.35B-24.40%-1.03B-25.03%-692.38M-15.08%-329.63M0.26%-1.16B
After-tax profit from continuing operations 10.94%1.63B-2.56%6.07B1.62%4.65B1.02%3.06B2.43%1.47B9.56%6.23B3.95%4.57B-2.64%3.03B-4.23%1.43B8.78%5.69B
Earning after tax 10.94%1.63B-2.56%6.07B1.62%4.65B1.02%3.06B2.43%1.47B9.56%6.23B3.95%4.57B-2.64%3.03B-4.23%1.43B8.78%5.69B
Minority profit -57.68%17.04M41.74%199.37M45.84%150.38M49.57%91.05M35.22%40.26M69.59%140.66M66.96%103.11M30.80%60.88M14.11%29.77M19.59%82.94M
Profit attributable to shareholders 12.88%1.61B-3.58%5.87B0.60%4.49B0.03%2.97B1.73%1.43B8.67%6.09B3.06%4.47B-3.15%2.97B-4.55%1.4B8.63%5.61B
Basic earnings per share 13.51%0.1361-3.21%0.49470.93%0.37840.24%0.24951.70%0.11999.00%0.51113.39%0.3749-2.85%0.2489-4.07%0.11798.64%0.4689
Diluted earnings per share 13.51%0.1361-3.21%0.49470.91%0.37830.24%0.24951.70%0.11999.00%0.51113.39%0.3749-2.85%0.2489-4.07%0.11798.64%0.4689
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKASHKASHKAS
Audit Opinions --Unqualified Opinion------Unqualified Opinion------Unqualified Opinion
Auditor --Deloitte - Guan Huang Chen Fang Certified Public Accountants------Deloitte - Guan Huang Chen Fang Certified Public Accountants------Deloitte - Guan Huang Chen Fang Certified Public Accountants

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg